Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer

Journal of Biochemistry

Volumn 154, Issue 5, 2013, Pages 395-408

  Heldin, Paraskevi ^a   Basu, Kaustuv ^a   Olofsson, Berit ^a   Porsch, Helena ^a   Kozlova, Inna ^a   Kahata, Kaoru ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Breast cancer; CD44; Hyaluronan; Hyaluronan synthases

Indexed keywords

HERMES ANTIGEN; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; RECEPTOR; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY; SYNTHETASE; UNCLASSIFIED DRUG;

BIODEGRADATION; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; DISEASE ASSOCIATION; DISTANT METASTASIS FREE SURVIVAL; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MAMMARY GLAND; NONHUMAN; PATHOLOGICAL ANATOMY; REGULATORY MECHANISM; REVIEW; STROMA; TURNOVER TIME; BINDING SITE; BIOSYNTHESIS; BREAST TUMOR; DISEASE COURSE; FEMALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTIGENS, CD44; BINDING SITES; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; SIGNAL TRANSDUCTION;

EID: 84890516990     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvt085     Document Type: Review

References (162)

1. Lu, P., Weaver, V.M., and Werb, Z. (2012) The extracellular matrix: A dynamic niche in cancer progression. J. Cell Biol. 196, 395-406
2. Sgroi, D.C. (2010) Preinvasive breast cancer. Annu. Rev. Pathol. 5, 193-221
3. Bissell, M.J., Rizki, A., and Mian, I.S. (2003) Tissue architecture: The ultimate regulator of breast epithelial function. Curr. Opin. Cell Biol. 15, 753-762
4. Hagenfeld, D., Borkenhagen, B., Schulz, T., Schillers, H., Schumacher, U., and Prehm, P. (2012) Hyaluronan export through plasma membranes depends on concurrent K efflux by K(ir) channels. PLoS One 7, e39096
5. Laurent, T.C. and Fraser, J.R.E. (1992) Hyaluronan. FASEB J. 6, 2397-2404
6. Tammi, R.H., Passi, A.G., Rilla, K., Karousou, E., Vigetti, D., Makkonen, K., and Tammi, M. (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J. 278, 1419-1428
7. Stern, R. and Jedrzejas, M.J. (2006) Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem. Rev. 106, 818-839
8. Stern, R. (2008) Hyaluronidases in cancer biology. Semin. Cancer Biol. 18, 275-80
9. Karihtala, P., Soini, Y., Auvinen, P., Tammi, R., Tammi, M., and Kosma, V.M. (2007) Hyaluronan in breast cancer: Correlations with nitric oxide synthases and tyrosine nitrosylation. J. Histochem. Cytochem. 55, 1191-1198
10. Slevin, M., Kumar, S., and Gaffney, J. (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277, 41046-41059
11. Pardue, E.L., Ibrahim, S., and Ramamurthi, A. (2008) Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 4, 203-214
12. West, D.C., Hampson, I.N., Arnold, F., and Kumar, S. (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1326
13. Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R.C., and Kumar, S. (2007) Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26, 58-68
14. Takahashi, Y., Li, L., Kamiryo, M., Asteriou, T., Moustakas, A., Yamashita, H., and Heldin, P. (2005) Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J. Biol. Chem. 280, 24195-24204
15. Fraser, J.R., Laurent, T.C., and Laurent, U.B. (1997) Hyaluronan: Its nature, distribution, functions and turnover. J. Intern. Med. 242, 27-33
16. Kabat, E.A. (1939) A polysaccharide in tumors due to a virus of leucosis and sarcoma of fowls. J. Biol. Chem. 130, 143-147
17. Toole, B.P., Biswas, C., and Gross, J. (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl Acad. Sci. USA 76, 6299-6303
18. Dahl, I.M.S., Solheim, ∅.P., Erikstein, B., and Mu ller, E. (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64, 68-73
19. Longaker, M.T., Adzick, N.S., Sadigh, D., Hendin, B., Stair, S.E., Duncan, B.W., Harrison, M.R., Spendlove, R., and Stern, R. (1990) Hyaluronic acid-stimulating activity in the pathophysiology of Wilms' tumors. J. Natl Cancer Inst. 82, 135-139
20. Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Agren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., and Kosma, V.M. (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 156, 529-536
21. Suwiwat, S., Ricciardelli, C., Tammi, R., Tammi, M., Auvinen, P., Kosma, V.M., LeBaron, R.G., Raymond, W.A., Tilley, W.D., and Horsfall, D.J. (2004) Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin. Cancer Res. 10, 2491-2498
22. Bertrand, P., Girard, N., Delpech, B., Duval, C., D'Anjou, J., and Dauce, J.P. (1992) Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non-invasive areas. Int. J. Cancer 52, 1-6
23. Wernicke, M., Pineiro, L.C., Caramutti, D., Dorn, V.G., Raffo, M.M., Guixa, H.G., Telenta, M., and Morandi, A.A. (2003) Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: A central role for hyaluronan. Mod. Pathol. 16, 99-107
24. Lipponen, P., Aaltomaa, S., Tammi, R., Tammi, M., Agren, U., and Kosma, V.M. (2001) High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur. J. Cancer 37, 849-856
25. Anttila, M.A., Tammi, R.H., Tammi, M.I., Syrjanen, K.J., Saarikoski, S.V., and Kosma, V.M. (2000) High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 60, 150-155
26. Kosunen, A., Ropponen, K., Kellokoski, J., Pukkila, M., Virtaniemi, J., Valtonen, H., Kumpulainen, E., Johansson, R., Tammi, R., Tammi, M., Nuutinen, J., and Kosma, V.M. (2004) Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol. 40, 257-263
27. Karjalainen, J.M., Tammi, R.H., Tammi, M.I., Eskelinen, M.J., Agren, U.M., Parkkinen, J.J., Alhava, E.M., and Kosma, V.M. (2000) Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am. J. Pathol. 157, 957-965
28. Kultti, A., Li, X., Jiang, P., Thompson, C.B., Frost, G.I., and Shepard, H.M. (2012) Therapeutic targeting of hyaluronan in the tumor stroma. Cancers 4, 873-903
29. Tammi, R.H., Kultti, A., Kosma, V.M., Pirinen, R., Auvinen, P., and Tammi, M.I. (2008) Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin. Cancer Biol. 18, 288-295
30. Decker, M., Chiu, E.S., Dollbaum, C., Moiin, A., Hall, J., Spendlove, R., Longaker, M.T., and Stern, R. (1989) Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res 49, 3499-3505
31. Asplund, T., Versnel, M.A., Laurent, T.C., and Heldin, P. (1993) Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res. 53, 388-392
32. Spicer, A.P., Seldin, M.F., Olsen, A.S., Brown, N., Wells, D.E., Doggett, N.A., Itano, N., Kimata, K., Inazawa, J., and McDonald, J.A. (1997) Chromosomal localization of the human and mouse hyaluronan synthase genes. Genomics 41, 493-497
33. Spicer, A.P. and McDonald, J.A. (1998) Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem. 273, 1923-1932
34. Spicer, A.P. and Tien, J.Y. (2004) Hyaluronan and morphogenesis. Birth Defects Res. C Embryo Today 72, 89-108
35. Heldin, P., Laurent, T.C., and Heldin, C.-H. (1989) Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem. J. 258, 919-922
36. Recklies, A.D., White, C., Melching, L., and Roughley, P.J. (2001) Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem. J. 354, 17-24
37. Suzuki, M., Asplund, T., Yamashita, H., Heldin, C.-H., and Heldin, P. (1995) Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-b1 involves activation of protein kinase C. Biochem. J. 307, 817-821
38. Jacobson, A., Brinck, J., Briskin, M.J., Spicer, A.P., and Heldin, P. (2000) Expression of human hyaluronan synthases in response to external stimuli. Biochem. J. 348(Pt 1), 29-35
39. Chao, H. and Spicer, A.P. (2005) Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation. J. Biol. Chem. 280, 27513-27522
40. Michael, D.R., Phillips, A.O., Krupa, A., Martin, J., Redman, J.E., Altaher, A., Neville, R. D., Webber, J., Kim, M.Y., and Bowen, T. (2011) The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. J. Biol. Chem. 286, 19523-19532
41. Linding, R., Russell, R.B., Neduva, V., and Gibson, T.J. (2003) GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res. 31, 3701-3708
42. Yoshida, M., Itano, N., Yamada, Y., and Kimata, K. (2000) In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity. J. Biol. Chem. 275, 497-506
43. Brinck, J. and Heldin, P. (1999) Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp. Cell Res. 252, 342-351
44. Heldin, P. (2009) Growth Factor Regulation of Hyaluronan Metabolism in Tumor Progression. http://www.glycoforum.gr.jp/(August 9, 2013, date last accessed
45. Itano, N. and Kimata, K. (2002) Mammalian hyaluronan synthases. IUBMB Life 54, 195-199
46. Karousou, E., Kamiryo, M., Skandalis, S.S., Ruusala, A., Asteriou, T., Passi, A., Yamashita, H., Hellman, U., Heldin, C.H., and Heldin, P. (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J. Biol. Chem. 285, 23647-23654
47. Heldin, P. and Pertoft, H. (1993) Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp. Cell Res. 208, 422-429
48. Heldin, P., Suzuki, M., Teder, P., and Pertoft, H. (1995) Chondroitin sulfate proteoglycan modulates the permeability of hyaluronan-containing coats around normal human mesothelial cells. J. Cell Phys. 165, 54-61
49. McBride, W.H. and Bard, J.B. (1979) Hyaluronidasesensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med. 149, 507-515
50. Adamia, S., Maxwell, C.A., and Pilarski, L.M. (2005) Hyaluronan and hyaluronan synthases: Potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5, 3-14
51. Ghosh, A., Kuppusamy, H., and Pilarski, L.M. (2009) Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: A potential mechanism promoting human cancer. J. Biol. Chem. 284, 18840-18850
52. Camenisch, T.D., Spicer, A.P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M.L., Calabro, A. Jr., Kubalak, S., Klewer, S.E., and McDonald, J.A. (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106, 349-360
53. McDonald, J.A. and Camenisch, T.D. (2003) Hyaluronan: Genetic insights into complex biology of a simple polysaccharide. Glycoconj. J. 19, 331-339
54. Porsch, H., Bernert, B., Mehic, M., Theoharis, A., Heldin, C.H., and Heldin, P. (2012) Efficient TGFbinduced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene 32, 4355-4365, (September 5, 2013, date last accessed
55. Li, Y., Rahmanian, M., Widstrom, C., Lepperdinger, G., Frost, G.I., and Heldin, P. (2000) Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am. J. Respir. Cell Mol. Biol. 23, 411-418
56. Li, L., Asteriou, T., Bernert, B., Heldin, C.H., and Heldin, P. (2007) Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: Importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem. J. 404, 327-336
57. Stuhlmeier, K.M. and Pollaschek, C. (2004) Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 Extracellular signal-regulated kinases/Mitogen-activated protein kinases (Erk/MAPK). pathway in TGF-beta-induced hyaluronan synthase 1 activation. J. Biol. Chem. 279, 8753-8760
58. Sayo, T., Sugiyama, Y., Takahashi, Y., Ozawa, N., Sakai, S., Ishikawa, O., Tamura, M., and Inoue, S. (2002) Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J. Invest. Dermatol. 118, 43-48
59. Karvinen, S., Pasonen-Seppanen, S., Hyttinen, J.M., Pienimaki, J.P., Torronen, K., Jokela, T.A., Tammi, M.I., and Tammi, R. (2003) Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and J. Biol. Chem. 278, 49495-49504
60. van den Boom, M., Sarbia, M., von Wnuck Lipinski, K., Mann, P., Meyer-Kirchrath, J., Rauch, B.H., Grabitz, K., Levkau, B., Schror, K., and Fischer, J.W. (2006) Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: Possible implications for vein graft stenosis. Circ. Res. 98, 36-44
61. Udabage, L., Brownlee, G.R., Nilsson, S.K., and Brown, T.J. (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp. Cell Res. 310, 205-217
62. Li, Y. and Heldin, P. (2001) Hyaluronan production increases the malignant properties of mesothelioma cells. Br. J. Cancer 85, 600-607
63. Jacobson, A., Rahmanian, M., Rubin, K., and Heldin, P. (2002) Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int. J. Cancer 102, 212-219
64. Itano, N., Atsumi, F., Sawai, T., Yamada, Y., Miyaishi, O., Senga, T., Hamaguchi, M., and Kimata, K. (2002) Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc. Natl Acad. Sci. USA 99, 3609-3614
65. Li, Y., Li, L., Brown, T.J., and Heldin, P. (2007) Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int. J. Cancer 120, 2557-2567
66. Udabage, L., Brownlee, G.R., Waltham, M., Blick, T., Walker, E.C., Heldin, P., Nilsson, S. K., Thompson, E.W., and Brown, T.J. (2005) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res. 65, 6139-6150
67. Bernert, B., Porsch, H., and Heldin, P. (2011) Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). J. Biol. Chem. 286, 42349-42359
68. Csoka, A.B., Frost, G.I., and Stern, R. (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20, 499-508
69. Frost, G.I., Csoka, A.B., Wong, T., and Stern, R. (1997) Purification, cloning, and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Commun. 236, 10-15
70. Lepperdinger, G., Mullegger, J., and Kreil, G. (2001) Hyal2-less active, but more versatile Matrix Biol. 20, 509-514
71. Simpson, M.A. and Lokeshwar, V.B. (2008) Hyaluronan and hyaluronidase in genitourinary tumors. Front. Biosci. 13, 5664-5680
72. Lokeshwar, V.B., Cerwinka, W.H., Isoyama, T., and Lokeshwar, B.L. (2005) HYAL1 hyaluronidase in prostate cancer: A tumor promoter and suppressor. Cancer Res. 65, 7782-7789
73. Rai, S.K., Duh, F.M., Vigdorovich, V., Danilkovitch- Miagkova, A., Lerman, M.I., and Miller, A.D. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl Acad. Sci. USA 98, 4443-4448
74. Harada, H. and Takahashi, M. (2007) CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem. 282, 5597-5607
75. Victor, R., Chauzy, C., Girard, N., Gioanni, J., d'Anjou, J., Stora De Novion, H., and Delpech, B. (1999) Human breast-cancer metastasis formation in a nude-mouse model: Studies of hyaluronidase, hyaluronan and hyaluronan- binding sites in metastatic cells. Int. J. Cancer 82, 77-83
76. Bertrand, P., Girard, N., Duval, C., d'Anjou, J., Chauzy, C., Menard, J.F., and Delpech, B. (1997) Increased hyaluronidase levels in breast tumor metastases. Int. J. Cancer 73, 327-331
77. Tan, J.X., Wang, X.Y., Li, H.Y., Su, X.L., Wang, L., Ran, L., Zheng, K., and Ren, G.S. (2011) HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Int. J. Cancer 128, 1303-1315
78. Beech, D.J., Madan, A.K., and Deng, N. (2002) Expression of PH-20 in normal and neoplastic breast tissue. J. Surg. Res. 103, 203-207
79. Tan, J.X., Wang, X.Y., Li, H.Y., Su, X.L., Wang, L., Ran, L., Zheng, K., and Ren, G.S. HYAL1 overexpression is correlated with the malignant behavior. of human breast cancer. Int. J. Cancer 128, 1303-1315
80. Underhill, C.B. and Toole, B.P. (1979) Binding of hyaluronate to the surface of cultured cells. J. Cell Biol. 82, 475-484
81. Turley, E.A. (1989) The role of a cell-associated hyaluronan- binding protein in fibroblast behaviour in The Biology of Hyaluronan (Evered, D. and Whehan, J., eds.), pp. 121-137, Chichester, Wiley
82. Nedvetzki, S., Gonen, E., Assayag, N., Reich, R., Williams, R.O., Thurmond, R.L., Huang, J.F., Neudecker, B.A., Wang, F.S., Turley, E.A., and Naor, D. (2004) RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44- knockout mice: A different interpretation of redundancy. Proc. Natl Acad. Sci. USA 101, 18081-18086
83. Turley, E.A. and Harrison, R. (1999) RHAMM, a Member of the Hyaladherins. http://glycoforum.gr.jp/science/hyaluronan/HA11/HA11E.html
84. Hall, C.L., Wang, C., Lange, L.A., and Turley, E.A. (1994) Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity, J. Cell Biol. 126, 575-588
85. Turley, E.A., Noble, P.W., and Bourguignon, L.Y. (2002) Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592
86. Tolg, C., Hamilton, S.R., Morningstar, L., Zhang, J., Zhang, S., Esguerra, K.V., Telmer, P. G., Luyt, L.G., Harrison, R., McCarthy, J.B., and Turley, E.A. (2010) RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity. J. Biol. Chem. 285, 26461-26474
87. Maxwell, C.A., Benitez, J., Gomez-Baldo, L., Osorio, A., Bonifaci, N., Fernandez-Ramires, R., Costes, S.V., Guino, E., Chen, H., Evans, G.J.R., Mohan, P., Catala, I., Petit, A., Aguilar, H., Villanueva, A., Aytes, A., Serra-Musach, J., Rennert, G., Lejbkowicz, F., Peterlongo, P., Manoukian, S., Peissel, B., Ripamonti, C.B., Bonanni, B., Viel, A., Allavena, A., Bernard, L., Radice, P., Friedman, E., Kaufman, B., Laitman, Y., Dubrovsky, M., Milgrom, R., Jakubowska, A., Cybulski, C., Gorski, B., Jaworska, K., Durda, K., Sukiennicki, G., Lubinski, J., Shugart, Y.Y., Domchek, S.M., Letrero, R., Weber, B.L., Hogervorst, F.B.L., Rookus, M.A., Collee, J.M., Devilee, P., Ligtenberg, M.J., van der Luijt, R.B., Aalfs, C.M., Waisfisz, Q., Wijnen, J., van Roozendaal, C.E.P., Easton, D.F., Peock, S., Cook, M., Oliver, C., Frost, D., Harrington, P., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Eccles, D., Douglas, F., Brewer, C., Nevanlinna, H., Heikkinen, T., Couch, F.J., Lindor, N.M., Wang, X.S., Godwin, A.K., Caligo, M.A., Lombardi, G., Loman, N., Karlsson, P., Ehrencrona, H., von Wachenfeldt, A., Barkardottir, R.B., Hamann, U., Rashid, M.U., Lasa, A., Caldes, T., Andres, R., Schmitt, M., Assmann, V., Stevens, K., Offit, K., Curado, J., Tilgner, H., Guigo, R., Aiza, G., Brunet, J., Castellsague, J., Martrat, G., Urruticoechea, A., Blanco, I., Tihomirova, L., Goldgar, D.E., Buys, S., John, E.M., Miron, A., Southey, M., Daly, M.B., Schmutzler, R.K., Wappenschmidt, B., Meindl, A., Arnold, N., Deissler, H., Varon-Mateeva, R., Sutter, C., Niederacher, D., Imyamitov, E., Sinilnikova, O.M., Stoppa-Lyonne, D., Mazoyer, S., Verny-Pierre, C., Castera, L., de Pauw, A., Bignon, Y.J., Uhrhammer, N., Peyrat, J.P., Vennin, P., Ferrer, S.F., Collonge-Rame, M.A., Mortemousque, I., Spurdle, A.B., Beesley, J., Chen, X.Q., Healey, S., Barcellos-Hoff, M.H., Vidal, M., Gruber, S.B., Lazaro, C., Capella, G., McGuffog, L., Nathanson, K.L., Antoniou, A.C., Chenevix-Trench, G., Fleisch, M.C., Moreno, V., Pujana, M.A., Hebon, Embrace, Swe-Brca, Bcfr, Collaborators, G.S., and Kconfab. (2011) Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol. 9, e1001199
88. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.B., and Seed, B. (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303-1313
89. Thorne, R.F., Legg, J.W., and Isacke, C.M. (2004) The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J. Cell Sci. 117, 373-380
90. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U., and Bell, J.I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl Acad. Sci. USA 89, 12160-12164
91. Orian-Rousseau, V. and Ponta, H. (2008) Adhesion proteins meet receptors: A common theme Adv. Cancer Res. 101, 63-92
92. Ponta, H., Sherman, L., and Herrlich, P.A. (2003) CD44: From adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4, 33-45
93. Louderbough, J.M. and Schroeder, J.A. (2011) Understanding the dual nature of CD44 in breast cancer progression. Mol. Cancer Res. 9, 1573-1586
94. Li, L., Heldin, C.H., and Heldin, P. (2006) Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J. Biol. Chem. 281, 26512-26519
95. Bourguignon, L.Y. (2001) CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J. Mammary Gland Biol. Neoplasia 6, 287-297
96. Skandalis, S.S., Kozlova, I., Engstrom, U., Hellman, U., and Heldin, P. (2010) Proteomic identification of CD44 interacting proteins. IUBMB Life 62, 833-840
97. Toole, B.P. (2009) Hyaluronan-CD44 interactions in cancer: Paradoxes and possibilities. Clin. Cancer Res. 15, 7462-7468
98. Toole, B.P. and Slomiany, M.G. (2008) Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells. Semin. Cancer Biol. 18, 244-250
99. Ghatak, S., Misra, S., and Toole, B.P. (2005) Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 280, 8875-8883
100. Zoller, M. (2011) CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule Nat. Rev. Cancer 11, 254-267
101. Kincade, P.W., Zheng, Z., Katoh, S., and Hanson, L. (1997) The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9, 635-642
102. Banerji, S., Wright, A.J., Noble, M., Mahoney, D.J., Campbell, I.D., Day, A.J., and Jackson, D.G. (2007) Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat. Struct. Mol. Biol. 14, 234-239
103. Ponta, H., Wainwright, D., and Herrlich, P. (1998) The CD44 protein family. Int. J. Biochem. Cell Biol. 30, 299-305
104. Day, A.J. and Prestwich, G.D. (2002) Hyaluronanbinding proteins: Tying up the giant. J. Biol. Chem. 277, 4585-4588
105. Masellis-Smith, A., Belch, A.R., Mant, M.J., Turley, E.A., and Pilarski, L.M. (1996) Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: Alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 87, 1891-1899
106. Savani, R.C., Cao, G., Pooler, P.M., Zaman, A., Zhou, Z., and DeLisser, H.M. (2001) Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 276, 36770-36778
107. Bono, P., Rubin, K., Higgins, J.M., and Hynes, R.O. (2001) Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol. Biol. Cell 12, 891-900
108. Huang, L., Grammatikakis, N., Yoneda, M., Banerjee, S.D., and Toole, B.P. (2000) Molecular characterization of a novel intracellular hyaluronan-binding protein. J. Biol. Chem. 275, 29829-29839
109. Itano, N., Zhuo, L., and Kimata, K. (2008) Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci. 99, 1720-1725
110. Koyama, H., Hibi, T., Isogai, Z., Yoneda, M., Fujimori, M., Amano, J., Kawakubo, M., Kannagi, R., Kimata, K., Taniguchi, S., and Itano, N. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: Possible involvement of versican/PG-M. Am. J. Pathol. 170, 1086-1099
111. Koyama, H., Kobayashi, N., Harada, M., Takeoka, M., Kawai, Y., Sano, K., Fujimori, M., Amano, J., Ohhashi, T., Kannagi, R., Kimata, K., Taniguchi, S., and Itano, N. (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: Pivotal role of a hyaluronan-rich tumor microenvironment. Am. J. Pathol. 172, 179-193
112. Teder, P. and Heldin, P. (1997) Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat. Am. J. Respir. Cell Mol. Biol. 17, 376-385
113. Teder, P., Vandivier, R.W., Jiang, D., Liang, J., Cohn, L., Pure, E., Henson, P.M., and Noble, P.W. (2002) Resolution of lung inflammation by CD44. Science 296, 155-158
114. Erickson, M. and Stern, R. (2012) Chain gangs: New aspects of hyaluronan metabolism. Biochem. Res. Int. 2012, 893947
115. Heldin, P., de la Torre, M., Ytterberg, D., and Bergh, J. (1996) Differential synthesis and binding of hyaluronan by human breast cancer cell lines: Relationship to hormone receptor status. Oncology Rep. 3, 1011-1016
116. Evanko, S.P., Parks, W.T., and Wight, T.N. (2004) Intracellular hyaluronan in arterial smooth muscle cells: Association with microtubules, RHAMM, and the mitotic spindle. J. Histochem. Cytochem. 52, 1525-1535
117. Malhotra, G.K., Zhao, X., Band, H., and Band, V. (2010) Histological, molecular and functional subtypes of breast cancers. Cancer Biol. Ther. 10, 955-960
118. Sandhu, R., Parker, J.S., Jones, W.D., Livasy, C.A., and Coleman, W.B. (2010) Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy. Labmedicine 41, 364-372
119. Parker, J.S., Mullins, M., Cheang, M.C., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., Quackenbush, J.F., Stijleman, I.J., Palazzo, J., Marron, J.S., Nobel, A.B., Mardis, E., Nielsen, T.O., Ellis, M.J., Perou, C.M., and Bernard, P.S. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160-1167
120. Bertos, N.R. and Park, M. (2011) Breast cancer - one term, many entities J. Clin. Invest. 121, 3789-3796
121. Hu, Z., Fan, C., Oh, D.S., Marron, J.S., He, X., Qaqish, B.F., Livasy, C., Carey, L.A., Reynolds, E., Dressler, L., Nobel, A., Parker, J., Ewend, M.G., Sawyer, L.R., Wu, J., Liu, Y., Nanda, R., Tretiakova, M., Ruiz Orrico, A., Dreher, D., Palazzo, J.P., Perreard, L., Nelson, E., Mone, M., Hansen, H., Mullins, M., Quackenbush, J.F., Ellis, M.J., Olopade, O.I., Bernard, P.S., and Perou, C.M. (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7, 96
122. Bergamaschi, A., Tagliabue, E., Sorlie, T., Naume, B., Triulzi, T., Orlandi, R., Russnes, H. G., Nesland, J.M., Tammi, R., Auvinen, P., Kosma, V.M., Menard, S., and Borresen-Dale, A.L. (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 214, 357-367
123. Bourguignon, L.Y., Zhu, H., Chu, A., Iida, N., Zhang, L., and Hung, M.C. (1997) Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J. Biol. Chem. 272, 27913-27918
124. Muschler, J. and Streuli, C.H. (2010) Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb. Perspect. Biol. 2, a003202
125. de la Torre, M., Wells, A.F., Bergh, J., and Lindgren, A. (1993) Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum. Pathol. 24, 1294-1297
126. Lochter, A. and Bissell, M.J. (1995) Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6, 165-173
127. Weigelt, B. and Bissell, M.J. (2008) Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin. Cancer Biol. 18, 311-321
128. Stern, R., Asari, A.A., and Sugahara, K.N. (2006) Hyaluronan fragments: An information-rich system. Eur. J. Cell Biol. 85, 699-715
129. Armstrong, S.E. and Bell, D.R. (2002) Measurement of high-molecular- weight hyaluronan in solid tissue using agarose gel electrophoresis. Anal. Biochem. 308, 255-264
130. Osterholt, H.C., Dannevig, I., Wyckoff, M.H., Liao, J., Akgul, Y., Ramgopal, M., Mija, D. S., Cheong, N., Longoria, C., Mahendroo, M., Nakstad, B., Saugstad, O.D., and Savani, R.C. (2012) Antioxidant protects against increases in low molecular weight hyaluronan and inflammation in asphyxiated newborn pigs resuscitated with 100% oxygen. PLoS One 7, e38839
131. Veiseh, M. and Turley, E.A. (2011) Hyaluronan metabolism in remodeling extracellular matrix: Probes for imaging and therapy of breast cancer. Integr. Biol. 3, 304-315
132. Day, A.J. and de la Motte, C.A. (2005) Hyaluronan cross-linking: A protective mechanism in inflammation Trends Immunol. 26, 637-643
133. de la Motte, C.A., Hascall, V.C., Drazba, J., Bandyopadhyay, S.K., and Strong, S.A. (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: Inter-alphatrypsin inhibitor is crucial to structure and function. Am. J. Pathol. 163, 121-133
134. de la Motte, C.A. (2011) Hyaluronan in intestinal homeostasis and inflammation: Implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G945-G949
135. Reed, R.K., Lilja, K., and Laurent, T.C. (1988) Hyaluronan in the rat with special reference to the skin. Acta Physiol. Scand. 134, 405-411
136. Ripellino, J.A., Klinger, A.M., Margolis, R.U., and Margolis, R.K. (1985) The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections, J. Histochem. Cytochem. 33, 1060-1066
137. Evanko, S.P. and Wight, T.N. (1999) Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 47, 1331-1342
138. de la Motte, C.A. and Drazba, J.A. (2011) Viewing hyaluronan: Imaging contributes to imagining new roles for this amazing matrix polymer. J. Histochem. Cytochem. 59, 252-257
139. Wight, T.N. (2002) Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14, 617-23
140. Kuang, D.M., Wu, Y., Chen, N., Cheng, J., Zhuang, S.M., and Zheng, L. (2007) Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110, 587-595
141. Mytar, B., Woloszyn, M., Szatanek, R., Baj- Krzyworzeka, M., Siedlar, M., Ruggiero, I., Wieckiewicz, J., and Zembala, M. (2003) Tumor cellinduced deactivation of human monocytes. J. Leukoc. Biol. 74, 1094-1101
142. Simpson, R.M., Wells, A., Thomas, D., Stephens, P., Steadman, R., and Phillips, A. (2010) Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. Am. J. Pathol. 176, 1215-1228
143. Okuda, H., Kobayashi, A., Xia, B., Watabe, M., Pai, S.K., Hirota, S., Xing, F., Liu, W., Pandey, P.R., Fukuda, K., Modur, V., Ghosh, A., Wilber, A., and Watabe, K. (2012) Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res. 72, 537-547
144. Sato, N., Maehara, N., and Goggins, M. (2004) Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 64, 6950-6956
145. Ramsden, C.A., Bankier, A., Brown, T.J., Cowen, P.S., Frost, G.I., McCallum, D.D., Studdert, V.P., and Fraser, J.R. (2000) A new disorder of hyaluronan metabolism associated with generalized folding and thickening of the skin. J. Pediatr. 136, 62-68
146. Olsson, M., Meadows, J.R., Truve, K., Rosengren Pielberg, G., Puppo, F., Mauceli, E., Quilez, J., Tonomura, N., Zanna, G., Docampo, M.J., Bassols, A., Avery, A.C., Karlsson, E. K., Thomas, A., Kastner, D.L., Bongcam-Rudloff, E., Webster, M.T., Sanchez, A., Hedhammar, A., Remmers, E.F., Andersson, L., Ferrer, L., Tintle, L., and Lindblad- Toh, K. (2011) A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogs. PLoS Genet. 7, e1001332
147. Basu, K., Sen, A., Ray, K., Ghosh, I., Datta, K., and Mukhopadhyay, A. (2012) Genetic association and gene-gene interaction of HAS2, HABP1 and HYAL3 implicate hyaluronan metabolic genes in glaucomatous neurodegeneration. Dis. Markers 33, 145-154
148. Unger, K., Wienberg, J., Riches, A., Hieber, L., Walch, A., Brown, A., O'Brien, P.C., Briscoe, C., Gray, L., Rodriguez, E., Jackl, G., Knijnenburg, J., Tallini, G., Ferguson-Smith, M., and Zitzelsberger, H. (2010) Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr. Relat. Cancer 17, 87-98
149. Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev- Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V., and Seluanov, A. (2013) High-molecular- mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 12234, doi:10.1038
150. Petersen, O.W., Nielsen, H.L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M.J., and Ronnov-Jessen, L. (2003) Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162, 391-402
151. Camenisch, T.D., Schroeder, J.A., Bradley, J., Klewer, S.E., and McDonald, J.A. (2002) Heart-valve mesenchyme formation is dependent on hyaluronanaugmented activation of ErbB2-ErbB3 receptors. Nat. Med. 8, 850-855
152. Zoltan-Jones, A., Huang, L., Ghatak, S., and Toole, B.P. (2003) Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J. Biol. Chem. 278, 45801-45810
153. Bakkers, J., Kramer, C., Pothof, J., Quaedvlieg, N.E.M., Spaink, H.P., and Hammerschmidt, M. (2004) Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation. Development 131, 525-537
154. Kozlova, I., Ruusala, A., Voytyuk, O., Skandalis, S.S., and Heldin, P. (2012) IQGAP1 regulates hyaluronanmediated fibroblast motility and proliferation. Cell Signal 24, 1856-1862
155. Oliferenko, S., Kaverina, I., Small, J.V., and Huber, L.A. (2000) Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. J. Cell Biol. 148, 1159-1164
156. Bourguignon, L.Y., Zhu, H., Shao, L., and Chen, Y.W. (2000) CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem. 275, 1829-1838
157. Jung, Y.S., Liu, X.W., Chirco, R., Warner, R.B., Fridman, R., and Kim, H.R. (2012) TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain. PLoS One 7, e38773
158. Ringner, M., Fredlund, E., Hakkinen, J., Borg, A., and Staaf, J. (2011) GOBO: Gene expression-based outcome for breast cancer online. PLoS One 6, e17911 159.
159. Morrison, H., Sherman, L.S., Legg, J., Banine, F., Isacke, C., Haipek, C.A., Gutmann, D.H., Ponta, H., and Herrlich, P. (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15, 968-980
160. Lopez, J.I., Camenisch, T.D., Stevens, M.V., Sands, B.J., McDonald, J., and Schroeder, J.A. (2005) CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res. 65, 6755-6763
161. Meyer, K. and Palmer, J.W. (1934) The polysaccharide of the viteous humor. J. Biol. Chem. 107, 629-634
162. Varadi, T., Mersich, T., Auvinen, P., Tammi, R., Tammi, M., Salamon, F., Besznyak, I., Jakab, F., Baranyai, Z., Szollosi, J., and Nagy, P. (2012) Binding of trastuzumab to erbb2 is inhibited by a high pericellular density of hyaluronan. J. Histochem. Cytochem. 60, 567-575